RhumbLine Advisers’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-80,917
| Closed | -$25.2K | – | 4229 |
|
|
2025
Q1 | $25.2K | Sell |
80,917
-3,161
| -4% | -$986 | ﹤0.01% | 3705 |
|
|
2024
Q4 | $78.5K | Buy |
84,078
+15,355
| +22% | +$14.3K | ﹤0.01% | 3543 |
|
|
2024
Q3 | $81.1K | Sell |
68,723
-1,010
| -1% | -$1.19K | ﹤0.01% | 3571 |
|
|
2024
Q2 | $53.6K | Sell |
69,733
-12,851
| -16% | -$9.88K | ﹤0.01% | 3663 |
|
|
2024
Q1 | $252K | Buy |
82,584
+2,918
| +4% | +$8.9K | ﹤0.01% | 3066 |
|
|
2023
Q4 | $257K | Sell |
79,666
-3,125
| -4% | -$10.1K | ﹤0.01% | 3058 |
|
|
2023
Q3 | $318K | Buy |
82,791
+4,023
| +5% | +$15.4K | ﹤0.01% | 2900 |
|
|
2023
Q2 | $258K | Buy |
+78,768
| New | +$258K | ﹤0.01% | 3099 |
|
|
2021
Q2 | – | Sell |
-48,990
| Closed | -$197K | – | 3077 |
|
|
2021
Q1 | $197K | Sell |
48,990
-680
| -1% | -$2.73K | ﹤0.01% | 2835 |
|
|
2020
Q4 | $115K | Buy |
49,670
+3,390
| +7% | +$7.85K | ﹤0.01% | 2952 |
|
|
2020
Q3 | $266K | Sell |
46,280
-1,945
| -4% | -$11.2K | ﹤0.01% | 2566 |
|
|
2020
Q2 | $355K | Buy |
+48,225
| New | +$355K | ﹤0.01% | 2491 |
|
|
2019
Q2 | – | Sell |
-17,010
| Closed | -$30K | – | 3000 |
|
|
2019
Q1 | $30K | Buy |
17,010
+459
| +3% | +$810 | ﹤0.01% | 2930 |
|
|
2018
Q4 | $40K | Buy |
16,551
+5,310
| +47% | +$12.8K | ﹤0.01% | 2956 |
|
|
2018
Q3 | $64K | Sell |
11,241
-575
| -5% | -$3.27K | ﹤0.01% | 2899 |
|
|
2018
Q2 | $92K | Buy |
+11,816
| New | +$92K | ﹤0.01% | 2879 |
|